Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-13-002099
Filing Date
2013-04-30
Accepted
2013-04-30 12:46:36
Documents
5
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2012a1_pathfinder.htm 10-K/A 320136
2 EXTENSION NO. 3 TO RESEARCH AGREEMENT DATED MARCH 23, 2009 BETWEEN THE UNIVERSIT f10k2012a1ex10xvb_path.htm EX-10.15B 20247
3 FORM OF PROMISSORY NOTES ISSUED BY REGISTRANT IN FAVOR OF INVESTORS DURING 2012 f10k2012a1ex10xxii_path.htm EX-10.22 64857
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-1 f10k2012a1ex31i_path.htm EX-31.1 5810
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-1 f10k2012a1ex31ii_path.htm EX-31.2 5289
  Complete submission text file 0001213900-13-002099.txt   417531
Mailing Address 12 BOW STREET CAMBRIDGE MA 02138
Business Address 12 BOW STREET CAMBRIDGE MA 02138 6172450289
Pathfinder Cell Therapy, Inc. (Filer) CIK: 0000889428 (see all company filings)

EIN.: 141745197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-20580 | Film No.: 13795730
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies